1. Introduction {#sec1-nutrients-12-01476}
===============

Sub-optimal diet quality is a leading cause of death in the United States and is estimated to contribute to approximately 44% of coronary heart disease deaths and 51% of stroke related deaths \[[@B1-nutrients-12-01476]\]. Data from clinical trials and prospective cohort studies indicate that healthy dietary patterns are associated with better metabolic health, lower risk of major chronic diseases, and lower mortality \[[@B2-nutrients-12-01476],[@B3-nutrients-12-01476],[@B4-nutrients-12-01476],[@B5-nutrients-12-01476]\]. These studies indicate that diet quality may be a key factor in the prevention and mitigation of chronic disease. Yet, the molecular mechanisms \[[@B2-nutrients-12-01476],[@B3-nutrients-12-01476]\] underlying the beneficial effects of healthy diet are not completely understood.

The identification of molecular biomarkers (proteins and metabolites) related to dietary patterns holds promise to elucidate biological pathways underlying the diet-related risk of chronic disease. Molecular biomarkers related to dietary intake may also relate to risk factors for chronic disease, or overt chronic disease per se. Such molecular markers reflecting dietary patterns have the potential to help inform risk assessment and allow for targeted preventive measures prior to the onset of chronic disease states. Population-based high-throughput proteomic studies of dietary patterns are lacking even though proteomic profiling may identify molecular biomarkers reflective of the biological functions/dysfunctions associated with an exposure (such as diet) or chronic disease states. In contrast, the use of untargeted metabolomics in nutrition research has increased in past years with the primary goal of biomarker discovery for the objective assessment of dietary intake \[[@B6-nutrients-12-01476]\]. Fewer studies have sought to relate dietary metabolomic profiles to disease outcomes; some studies have suggested that certain circulating metabolites may contribute to the biological underpinnings of diet--disease relations \[[@B7-nutrients-12-01476],[@B8-nutrients-12-01476],[@B9-nutrients-12-01476]\].

Multi-level omics analyses that combine high-dimensional molecular data from high throughput platforms can provide a comprehensive assessment of intermediate phenotypes (e.g., molecular endophenotypes) that may help link diet (or other exposures) to more distal chronic disease phenotypes. We hypothesized that proteomic and metabolic signatures of habitual dietary patterns encompass the respective functional states and metabolic consequences of unique dietary patterns including the sequelae of chronic disease. The objective of the present investigation was to determine the associations of the Alternative Healthy Eating Index (AHEI), Dietary Approaches to Stop Hypertension (DASH) diet, and a Mediterranean-style diet (MDS) with 1373 plasma proteins and 216 circulating metabolites in a sample of community-dwelling middle-aged adults.

2. Materials and Methods {#sec2-nutrients-12-01476}
========================

2.1. Study Sample {#sec2dot1-nutrients-12-01476}
-----------------

The description of the Framingham Offspring Study is located elsewhere \[[@B10-nutrients-12-01476]\]. For the present investigation, we evaluated data from participants who attended the fifth examination cycle (1991--1995) of the Framingham Offspring Study. Details of participant inclusion are displayed in [Supplementary Figure S1](#app1-nutrients-12-01476){ref-type="app"}. For our analyses of diet--protein relations, 1913 participants who had proteomic profiling completed on the SOMAscan platform were eligible. Participants were excluded from analysis if they did not have complete dietary data (*n* = 200) or had missing covariate data (*n* = 51). This resulted in a final analytical sample of 1662. For analyses of diet--metabolite relations, 2526 participants who had metabolites assayed were eligible. Participants were excluded from analysis if they did not have complete dietary data (*n* = 242) or if they were missing covariate data (*n* = 76). This resulted in a second analytical sample of 2208 for diet--metabolite relations.

2.2. Protein Quantification {#sec2dot2-nutrients-12-01476}
---------------------------

Proteomics profiling in the Framingham Offspring Study has been described previously \[[@B11-nutrients-12-01476],[@B12-nutrients-12-01476]\]. Blood samples were collected from participants at the fifth exam Heart Study visit using standard phlebotomy procedures. Using the SOMAscan platform, a total of 1373 proteins were quantified using single-stranded DNA-based aptamers. Samples were assayed in two batches (*n* = 821 and *n* = 1092). For each respective batch, age and sex adjusted protein values were log~e~ transformed and standardized to a mean = 0 and standard deviation (SD) = 1. The inter- and intra-assay reproducibility of proteins quantified on the SOMAscan platform in the Framingham Offspring Study has previously been reported \[[@B11-nutrients-12-01476]\].

2.3. Metabolite Quantification {#sec2dot3-nutrients-12-01476}
------------------------------

Measurements of 216 metabolites in the Framingham Offspring Study has been previously described in detail \[[@B13-nutrients-12-01476],[@B14-nutrients-12-01476],[@B15-nutrients-12-01476]\]. Blood samples were collected at the fifth exam Heart Study visit. Positively charged polar, negatively charged polar, and lipid metabolites were quantified using liquid chromatography with tandem mass spectrometry (LC/MS/MS). Known standards were used to identify metabolites and internal standards were used for quality control \[[@B13-nutrients-12-01476]\]. Nomenclature for lipid metabolites includes the total lipid acyl chain-length followed by the total number of double bonds (e.g., twenty-two carbon acyl chain and six double bonds is indicated by = C22:6).

2.4. Dietary Assessment {#sec2dot4-nutrients-12-01476}
-----------------------

Dietary intake at examination cycle five was assessed using the Harvard semi-quantitative food frequency questionnaire (FFQ). The Harvard FFQ measures usual frequency of consumption of 126 dietary items over the year preceding the Heart Study visit. Food frequency categories range from none or \<1 serving per month to ≥ 6 servings per day. Use of the Harvard FFQ has previously been validated for the assessment of dietary intake using 7-day dietary records \[[@B16-nutrients-12-01476]\]. We only used FFQs that were considered valid (\<13 blank items and estimated daily caloric intake was ≥600 kcal/d and \<4000 kcal/d for women or \<4200 kcal/d for men) \[[@B17-nutrients-12-01476]\].

2.5. Dietary Pattern Indices {#sec2dot5-nutrients-12-01476}
----------------------------

The AHEI, DASH diet score, and MDS were constructed using dietary intake data from the aforementioned FFQ. Components and scoring criteria for each score were based on prior studies and have been described in detail elsewhere \[[@B18-nutrients-12-01476],[@B19-nutrients-12-01476],[@B20-nutrients-12-01476]\].

AHEI components include vegetables, fruits, nuts and legumes, sugar-sweetened beverages and fruit juice, whole grains, red and processed meat, eicosapentaenoic acid and docosahexaenoic acid, polyunsaturated fatty acids (PUFA), *trans* fatty acids, sodium, and alcohol \[[@B20-nutrients-12-01476]\]. For each component, a maximum score of 10 points was possible. Reverse scores (lower consumption receives a higher score) were assigned to sugar-sweetened beverages, *trans* fatty acids, and sodium. Individual components were summed to a maximum total score of 110 points.

The DASH diet score has 8 components, which includes fruits and fruit juices, vegetables, nuts and legumes, whole grains, low-fat dairy, sodium, red and processed meats, and sugar-sweetened beverages. For each component, scoring was based on quintiles of intake with the first quintile (Q1) receiving a score of 1 and the fifth quintile (Q5) receiving the maximum score of 5 points \[[@B19-nutrients-12-01476]\]. Reverse scores were assigned to sodium, red and processed meats, and sugar-sweetened beverages. All components were summed to a maximum DASH diet score of 40.

Lastly, the MDS components included vegetables, fruits, nuts, legumes, whole grains, fish, red meat, ratio of monounsaturated fatty acids (MUFA) to saturated fatty acids (SFA), and alcohol. Except for alcohol, all component scores are based on sex-specific quartiles of intake for our respective sample, with participants in the first quartile (Q1) receiving a score of 0 and the fourth quartile (Q4) having the maximum score of 3 \[[@B21-nutrients-12-01476]\]. Reverse scores were assigned to red and processed meat component. Participants received a score of 1 for sex-specific moderate alcohol consumption or a score of 0 for over- or under-consumption \[[@B18-nutrients-12-01476]\]. Component scores were summed to a maximum final MDS score of 25.

2.6. Covariate Assessment {#sec2dot6-nutrients-12-01476}
-------------------------

We included the following covariates in our analysis: age, sex, total caloric intake, current smoking status, physical activity index, use of lipid lowering medication, use of anti-hypertensive medication, and body mass index (BMI). All covariates were assessed at the fifth examination cycle of the Framingham Offspring Study (1991--1995). We classified participants who smoked regularly in the year preceding the Heart Study visit as current smokers. Use of anti-hypertensive and lipid-lowering medications in the past year was based on self-report. BMI was calculated as measured weight in kilograms divided by the square of height in meters (kg/m^2^). The physical activity index was calculated based on time and intensity of activities in a day \[[@B22-nutrients-12-01476]\]. Lastly, total energy was calculated from the aforementioned semi-quantitative FFQ.

2.7. Statistical Analysis {#sec2dot7-nutrients-12-01476}
-------------------------

We used multivariable linear regression models to determine the cross-sectional associations of each dietary pattern index (AHEI, DASH, and MDS; independent variables, a separate model for each) with each protein and metabolite (dependent variables, a separate model for each). We standardized all three dietary pattern indices (mean = 0, SD = 1) and modeled the standardized scores as continuous variable to maximize our statistical power. Results are reported as increments in proteins or metabolite concentrations for each SD-unit increase in the standardized dietary pattern indices (AHEI, DASH or MDS). Multivariable linear regression models included adjustment for age, sex, total caloric intake, current smoking status, physical activity index, use of lipid lowering medication, use of anti-hypertensive medication, and BMI. We calculated age- and sex-adjusted Spearman's correlation coefficients among proteins and metabolites (separately) identified as statistically significant in our second multivariable regression model.

For all analyses we considered the Benjamini--Hochberg false discover rate (FDR) q value of ≤0.05 to define statistical significance. A Bonferroni adjustment (0.05/1373 proteins and 0.05/216 metabolites) was used to display a condensed list of top significant proteins and metabolites. Statistical analyses were completed using SAS statistical software (version 9.4; SAS Institute, Cary, NC, USA) and R (version 3.6.1) run on RStudio (RStudio: Integrated Development for R. RStudio, Inc., Boston, MA, USA).

2.8. Enrichment Analysis {#sec2dot8-nutrients-12-01476}
------------------------

We completed an enrichment analysis to determine underlying biological significance of proteins that have statistically significant associations with dietary patterns. A pathway over-representation analysis was conducted on significant (FDR q ≤ 0.05) proteins using Web-based Gene Set Analysis Toolkit (WebGestalt) \[[@B23-nutrients-12-01476]\]. Proteins were mapped to the Kyoto Encyclopedia of Genes and Genomes (KEGG) functional database \[[@B24-nutrients-12-01476]\]. KEGG pathways with less than 5 proteins or more than 2000 proteins were excluded from the analysis. Enriched pathways with an FDR q ≤ 0.05 were considered statistically significant. Significant metabolites were mapped to the KEGG functional database for descriptive annotation.

### Overlap between Dietary Protein and Metabolite Quantitative Trait Loci and Prior Genome-Wide Association Study Risk Loci

Previous work in the Framingham Offspring Study has identified genetic loci (protein and metabolite quantitative trait loci \[p/mQTL\]) of 156 of the proteins and all of the 216 metabolites assayed at examination cycle five \[[@B25-nutrients-12-01476],[@B26-nutrients-12-01476]\]. Genotyping and the identification of p/mQTLs in the Framingham Offspring Study have been described elsewhere \[[@B25-nutrients-12-01476],[@B26-nutrients-12-01476]\]. In the present study, we present p/mQTL that were previously identified in the Framingham Offspring Study to be associated with proteins and/or metabolites that we observed to be significantly associated with at least one of the respective dietary patterns. We searched the NHGRI-EBI Catalogue of Published genome-wide association studies (GWAS) \[[@B27-nutrients-12-01476]\] to determine overlap between dietary p/mQTL and risk loci identified in prior GWAS.

3. Results {#sec3-nutrients-12-01476}
==========

3.1. Sample Characteristics {#sec3dot1-nutrients-12-01476}
---------------------------

Our overall study sample had an average age of 55 years and 52 percent were women. Sex-specific participant characteristics, represented as mean (SD) or frequency (proportion), are displayed in [Table 1](#nutrients-12-01476-t001){ref-type="table"}. On average, women had a lower BMI and a small proportion reported use of lipid-lowering and anti-hypertensive medications, compared to men. Additionally, women reported a lower average energy intake and had higher average AHEI and DASH dietary pattern scores.

3.2. Associations of Dietary Patterns with Plasma Protein Concentrations {#sec3dot2-nutrients-12-01476}
------------------------------------------------------------------------

Overall, 103 unique proteins were significantly associated with at least one dietary pattern index (48 with AHEI, 83 with DASH, and 8 with MDS; [Figure 1](#nutrients-12-01476-f001){ref-type="fig"}A). Forty-six proteins were directly associated with at least one dietary pattern index and 57 proteins had inverse associations with at least one dietary pattern index ([Figure 2](#nutrients-12-01476-f002){ref-type="fig"}A). The top significant results by a Bonferroni adjustment are listed in [Table 2](#nutrients-12-01476-t002){ref-type="table"}. Beta coefficients representing the difference in concentrations of each of the 103 proteins per SD increase in the AHEI, DASH and MDS indices are listed in [Supplemental Table S1](#app1-nutrients-12-01476){ref-type="app"}. Five proteins (epidermal growth factor receptor \[ERBB1\], kynureninase \[KYNU\], stanniocalcin 1, macrophage migration inhibitory factor \[MIF\], and WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 2 \[WFKN2\]) were significantly associated with all three dietary pattern indices. We observed that 52 proteins were uniquely associated with the DASH diet score (19 direct and 33 inverse associations; all FDR q ≤ 0.05) and 17 proteins were uniquely associated with the AHEI (7 direct and 10 inverse associations; all FDR q ≤ 0.05). Additionally, 26 proteins were significantly associated with the DASH diet score and the AHEI but not the MDS (15 direct and 11 inverse associations; all FDR q ≤ 0.05). Unlike the DASH diet score and the AHEI, associations of the MDS with plasma proteins were less evident. The MDS was significantly associated with just 8 proteins, 3 of which (p-selectin, intercellular adhesion molecular 5 \[ICAM-5\], and cathepsin S) uniquely related to the MDS (all FDR q ≤ 0.05). Among the 103 unique proteins, we observed two groupings of positively correlated proteins (34 proteins and 40 proteins; [Figure 3](#nutrients-12-01476-f003){ref-type="fig"}). The first grouping consists of 34 proteins that primarily had inverse associations with dietary patterns and the second grouping consists of 40 proteins that primarily had positive associations with dietary patterns.

3.3. Associations of Dietary Patterns with Plasma Metabolite Concentrations {#sec3dot3-nutrients-12-01476}
---------------------------------------------------------------------------

Of the 216 plasma metabolites, 65 were associated with at least one dietary pattern index (38 with AHEI, 43 with DASH, 50 with MDS; all FDR q ≤ 0.05; [Figure 1](#nutrients-12-01476-f001){ref-type="fig"}B and [Figure 2](#nutrients-12-01476-f002){ref-type="fig"}B). Of these, 27 metabolites had direct associations and 38 metabolites had inverse associations with a dietary pattern. The top statistically significant results after a Bonferroni correction are listed in [Table 3](#nutrients-12-01476-t003){ref-type="table"}. Beta coefficients representing the difference in concentrations of each of the 65 proteins per one-unit increase in the AHEI, DASH and MDS indices are listed in [Supplemental Table S2](#app1-nutrients-12-01476){ref-type="app"}. The majority of statistically significant metabolites associated with the three dietary patterns were lipids (55%). Additional notable classes of molecules associated with the three dietary patterns included amino acids (11%), bile acids and derivatives (5%), nucleotide metabolism (5%), and tricarboxylic acid and derivatives (5%). We observed that 24 metabolites were significantly associated (15 directly and 9 inversely) with all three dietary pattern indices (all FDR q ≤ 0.05). Half of the 24 metabolites were highly-unsaturated lipid species directly associated with the respective diet indices. Overall, we observed fewer significant unique associations of the three dietary pattern indices with metabolites than with proteins. The MDS was uniquely associated with 11 lipid species and the nucleotide metabolite adenosine monophosphate (AMP, all FDR q ≤ 0.05). The AHEI and DASH indices had fewer unique associations (5 and 6 respectively), all of which were with non-lipid metabolites (all FDR q ≤ 0.05). Of the 65 metabolites, we observed that concentrations of lipid species with a similar degree of saturation had direct correlations with each other ([Figure 4](#nutrients-12-01476-f004){ref-type="fig"}).

3.4. Protein Enrichment Analysis {#sec3dot4-nutrients-12-01476}
--------------------------------

We completed a pathway over-representation analysis of the 103 proteins significantly associated with the AHEI, DASH, or MDS diet indices. Sixty-eight proteins successfully mapped to KEGG pathways. The top ten enriched pathways for these 68 proteins are displayed in [Table 4](#nutrients-12-01476-t004){ref-type="table"}. Seven pathways were significantly enriched by protein related to dietary patterns: complement and coagulation cascades, staphylococcus aureus infection, endocrine resistance, HIF-1 signaling pathway, central carbon metabolism in cancer, PI3K-Akt signaling pathway, and malaria (all FDR q ≤ 0.05). Additionally, three pathways had FDR q \< 0.07, including fluid shear stress and atherosclerosis, Prostate cancer, and cell adhesion molecules (CAMs). Pathways were broadly involved in biological processes such as cellular proliferation, cellular metabolism, immune response, and inflammation. We completed separate analyses on the 48 proteins significantly associated with the AHEI and the 83 proteins significantly associated with the DASH diet score ([Supplementary Table S3](#app1-nutrients-12-01476){ref-type="app"}). Thirty-seven of the 48 proteins associated with the AHEI and 49 of the 83 protein associated with the DASH diet score successfully mapped to KEGG pathways. This secondary enrichment analysis suggested that proteins associated with the DASH diet score predominately enriched the HIF-1 signaling pathway, PI3K-Akt signaling pathway, malaria, fluid shear stress and atherosclerosis, and prostate cancer pathways.

3.5. Metabolite Enrichment {#sec3dot5-nutrients-12-01476}
--------------------------

In a descriptive assessment, we mapped metabolites to pathways in the KEGG functional database ([Supplemental Table S4](#app1-nutrients-12-01476){ref-type="app"}). Metabolites mapped to notable pathways including bile secretion, cholesterol metabolism, and ABC transporters. Additional pathways include choline metabolism, glycerophospholipid metabolism, and vitamin digestion and absorption.

3.6. Overlap between Dietary Protein and Metabolite Quantitative Trait Loci and Prior Genome-Wide Association Study Risk Loci {#sec3dot6-nutrients-12-01476}
-----------------------------------------------------------------------------------------------------------------------------

Of the previously identified genetic loci associated with 156 proteins from the SOMAscan platform, 39 were related with concentrations of 25 plasma proteins that we identified as having a significant association with at least one respective dietary pattern index ([Table 5](#nutrients-12-01476-t005){ref-type="table"}). Four of these dietary pQTL were associated with clinical traits in prior GWAS analyses. In particular, a variant (rs2519093) of the *ABO* gene, which is directly associated with concentrations of E-selectin, has direct associations with coronary artery disease \[[@B28-nutrients-12-01476]\], venous thromboembolism \[[@B29-nutrients-12-01476]\], and cardiometabolic risk factors. Additionally, 19 mQTL were associated with concentrations of 18 metabolites, 15 of which are lipid metabolites ([Table 6](#nutrients-12-01476-t006){ref-type="table"}). Many lipid metabolites were associated with genetic variants of the of the fatty acid desaturase gene family \[*FADS1-2*\]. Genetic variants of the FADS gene cluster are associated with plasma concentrations of omega-3 and -6 fatty acids \[[@B30-nutrients-12-01476],[@B31-nutrients-12-01476]\], and cardiometabolic risk factors (blood lipids, insulin, and glycemic markers) \[[@B32-nutrients-12-01476],[@B33-nutrients-12-01476]\]. Further, a genetic variant of the *APOA* gene cluster was associated with concentrations of TAG (C52:4) and has been linked to increased susceptibility of CVD \[[@B34-nutrients-12-01476]\].

4. Discussion {#sec4-nutrients-12-01476}
=============

Proteomic and metabolomic correlates of dietary patterns (sometimes referred to as 'signatures') may collectively represent an intermediate phenotype of the underlying metabolic state and provide insight into the molecular mechanisms mediating diet and chronic disease associations. In the present investigation we identified high-throughput proteomic *and* metabolomic signatures of dietary patterns that have been previously associated with reduced risk of chronic disease mortality from all causes \[[@B4-nutrients-12-01476],[@B5-nutrients-12-01476]\]. Our main findings are four-fold; first, we identified unique proteomic correlates of the DASH and AHEI dietary patterns. Second, we identified a shared 'signature' of 24 metabolites associated with all three healthy dietary patterns. Third, downstream enrichment analysis indicated that proteins associated with dietary patterns are involved in biological pathways that may underlie associations between dietary patterns and metabolic health. Fourth, overlap between dietary p/mQTL and prior GWAS risk loci suggest the potential utility of dietary pattern-related proteins and metabolites as endophenotypes that may link diet to cardiometabolic health and risk of chronic disease.

Our investigation adds to the literature by relating a broad array of over 1300 plasma proteins to dietary patterns using multiplexed high-throughput single-stranded DNA aptamer technology that allows for efficient and deep profiling of the plasma proteome \[[@B35-nutrients-12-01476]\]. Of the 103 dietary pattern-related proteins in our investigation, 16 were associated with various metabolic traits (BMI, visceral adiposity, triglycerides, insulin resistance, and fasting glucose) in the Diet, Obesity, and Genes interventional trial \[[@B36-nutrients-12-01476],[@B37-nutrients-12-01476]\] and 45 proteins were associated with cardiometabolic risk and/or incidence CVD in the Framingham Offspring Study \[[@B11-nutrients-12-01476]\]. In addition, our over representation analysis indicated that diet related proteins enriched biological pathways involved in cellular proliferation/metabolism and immune response/inflammation. However, we observed considerable overlap of proteins among the identified pathways. The relatively modest number of proteins that successfully mapped to KEGG pathways may have hindered a thorough enrichment analysis. Lastly, our observation that concentrations of E selectin were related to a poorer DASH diet score and a variant of the *ABO* gene that is directly associated with CAD may delineate a functional link between diet and metabolic health.

To the best of our knowledge, only two prior studies have examined proteomic profiles of dietary patterns \[[@B38-nutrients-12-01476],[@B39-nutrients-12-01476]\]. A recent investigation by Warensjo Lemming et al. examined a panel of 184 proteins and identified 59 proteins associated with Swedish population empirically derived dietary patterns; 21 of which were validated in an independent cohort \[[@B39-nutrients-12-01476]\]. We observed significant positive associations with five of the 21 proteins (ERBB1 \[EGFR\], insulin like growth factor binding protein 1 \[IGFBP1\], programmed death ligand 2 \[PDL2\], galectin-3 \[Gal3\], and contactin 1 \[CNTN1\]) that are involved in processes including cellular metabolism, cellular proliferation, immune response, and cellular adhesion. Prior experimental studies indicate that gene and/or protein expression of ERBB1, PDL2, and CNTN1 is atheroprotective \[[@B40-nutrients-12-01476],[@B41-nutrients-12-01476],[@B42-nutrients-12-01476]\]. Further, multiple studies have reported that low concentrations of IGEBP1 are directly associated with glucose intolerance and risk of diabetes mellitus \[[@B43-nutrients-12-01476],[@B44-nutrients-12-01476]\]. Notably, ERBB1 and CNTN1 were found to be inversely associated with cardiometabolic risk and/or incidence CVD \[[@B11-nutrients-12-01476],[@B45-nutrients-12-01476]\]. In contrast, prior work has identified direct associations between Gal3 and heart failure \[[@B46-nutrients-12-01476]\]. Thus, the direct association of Gal3 with healthy dietary patterns warrants further investigation.

Perhaps our most intriguing finding is the unique proteomic signatures, or lack thereof, we observed across dietary patterns. Notably, the DASH diet score was associated with a unique signature of 52 proteins, which enriched pathways involved in cellular metabolism, hypoxia, inflammation, and atherosclerosis. Clinical trials have demonstrated the efficacy of the DASH diet in lowering blood pressure \[[@B3-nutrients-12-01476]\] and epidemiological studies have found that adherence to the DASH diet is associated with reduced risk of hypertension, CVD, and mortality \[[@B19-nutrients-12-01476],[@B47-nutrients-12-01476],[@B48-nutrients-12-01476]\]. Additional studies are needed to determine if proteins in this unique signature are associated with blood pressure lowering and other cardio-protective qualities of the DASH diet.

Similar to our investigation, two prior studies comparing hypothesis-driven dietary patterns reported just a modest number of unique dietary pattern and metabolite associations \[[@B49-nutrients-12-01476],[@B50-nutrients-12-01476]\]. A higher degree of similarities across metabolomic signatures of healthy dietary patterns might indicate a generalized metabolic response of an overall healthy dietary pattern. Prior studies have reported that a large proportion of the metabolites associated with dietary patterns are lipids \[[@B49-nutrients-12-01476],[@B50-nutrients-12-01476],[@B51-nutrients-12-01476]\]. Lipids represented 63% of the metabolites associated with all three dietary patterns. We observed that lipids directly associated with a higher diet quality tended to have ≥5 carbon double bonds. Further, we observed that genetic variants (rs174548 and rs174550) associated with distinct highly-unsaturated lipid species had concordant associations with blood triglycerides and high-density lipoprotein metabolism \[[@B52-nutrients-12-01476],[@B53-nutrients-12-01476]\]. Previous studies have found that highly-unsaturated lipids, with a longer acyl-chain length have inverse associations with risk of CVD and diabetes mellitus \[[@B54-nutrients-12-01476],[@B55-nutrients-12-01476],[@B56-nutrients-12-01476],[@B57-nutrients-12-01476]\]. Hence, lipid correlates of dietary patterns, particularly highly-unsaturated lipids, may serve as markers of overall diet quality and may be directly related to pathogenesis of cardiometabolic and other chronic disease risks.

Lastly, we note that concentrations of several metabolites associated with the respective dietary patterns could be influenced by composition of the gut microbiome. This includes metabolites involved in choline metabolism (phosphotidylcholine, choline, and betaine), bile acid metabolism (glycocholate, deoxycholate, and deoxyglycholoate), and amino acid metabolism (tryptophan, indoxylsufate, proline, and hydroxyproline). Such metabolites have previously been linked to inflammation, chronic kidney disease, and CVD \[[@B58-nutrients-12-01476],[@B59-nutrients-12-01476],[@B60-nutrients-12-01476],[@B61-nutrients-12-01476]\]. Metabolites related to dietary patterns and the gut microbiome may represent the functional response of diet---microbial interactions that influence metabolic health, a premise that warrants further evaluation.

The present study has several strengths. The Framingham Offspring Study is a well-established cohort with a comprehensive assessment of phenotypic, lifestyle, and dietary data on participants. We used a multiplexed aptamer-based high-throughput assay to identify and quantify a large number of plasma proteins. Lastly, we assessed three complementary dietary pattern indices that are extensively reviewed in the literature and can be readily reproduced in other study populations. Limitations of our investigation include the use of self-reported dietary data, which is prone to measurement error that may lead to misclassification and attenuation of observed associations. A more comprehensive metabolomic profile would aid in direct comparisons across studies. A large proportion of the metabolites associated with dietary patterns were lipid species that do not map to the KEGG functional database. This precluded a thorough enrichment analysis of metabolites related to dietary patterns. Participants from the Framingham Offspring Study are predominantly white and of European ancestry. Hence, our results may not be generalizable across populations that are more racially/ethnically diverse. We conducted a cross-sectional analysis and, therefore, cannot determine causality of any of the observed associations, and cannot exclude the possibility of uncontrolled or residual confounding.

In summary, the present investigation identified proteomic and metabolomic correlates of three dietary patterns. The DASH and AHEI were associated with unique proteomic signatures; whereas the largest metabolomic 'signature' was associated with all three dietary patterns. Proteins and metabolites related to dietary patterns may have prognostic value and inform future clinical interventions. Additional work, in in vitro and in vivo settings, is warranted to identify genetic determinants of dietary correlates and examine how they may relate to the progression of modifiable chronic disease. Findings from this investigation will require replication in independent and ethnically diverse populations.
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The following are available online at <https://www.mdpi.com/2072-6643/12/5/1476/s1>, Supplementary Figure S1. Participant flow diagram, Supplementary Table S1. Statistically significant associations of dietary patterns with plasma protein concentrations, Supplementary Table S2. Statistically significant associations of dietary patterns with plasma metabolite concentrations, Supplementary Table S3. Pathway over representation analysis of protein markers associated with the AHEI and DASH dietary pattern indices, Supplementary Table S4. KEGG pathway mapping of metabolites associated with dietary pattern indices.
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![The number of protein (**A**) and metabolite (**B**) markers associated with dietary pattern indices. Venn diagrams illustrate the overlap of significant proteins (FDR q ≤ 0.05) and metabolites across the AHEI, DASH, and MDS dietary patterns. Significant proteins and metabolites were based on a false discovery rate threshold ≤ 0.05 from multivariable models adjusted for age, sex, total caloric intake, current smoking, physical activity index, lipid lowering medication, anti-hypertensive medication, and body mass index. Abbreviations: AHEI, Alternative Healthy Eating Index; DASH, Dietary Approaches to Stop Hypertension; FDR, false discovery rate; MDS, Mediterranean-style Diet Score.](nutrients-12-01476-g001){#nutrients-12-01476-f001}

![Protein (**A**) and metabolite (**B**) markers associated with dietary pattern indices. Colored points (red, green, blue) indicate statistical significance (FDR q ≤ 0.05) by the respective dietary pattern indices. Multivariable regression models are adjusted for age, sex, total caloric intake, current smoking, physical activity index, lipid lowering medication, anti-hypertensive medication, and body mass index. β estimates represent the change in marker per one-unit increase in the respective dietary pattern indices. Eleven metabolites with β coefficients \< −0.50 or \>0.50 are excluded from the figure. Abbreviations: AHEI, Alternative Healthy Eating Index; CE, cholesterol ester; DASH, Dietary Approaches to Stop Hypertension; FDR, false discovery rate; LPC, lysophosphatidylcholine; LPE, lysophosphatidylethanolamine; MDS, Mediterranean-style Diet Score. PC, phosphatidylcholine; SM, sphingomyelin; TAG, triacylglycerol.](nutrients-12-01476-g002){#nutrients-12-01476-f002}

![Heatmap depicting Spearman's partial correlation coefficients adjusted for age and sex between proteins that were statistically significant (FDR p ≤ 0.05) in multivariable models adjusting for age, sex, total caloric intake, current smoking, physical activity index, lipid lowering medication, anti-hypertensive medication, and body mass index.](nutrients-12-01476-g003){#nutrients-12-01476-f003}

![Heatmap depicting Spearman's partial correlation coefficients adjusted for age and sex between metabolites that were statistically significant (FDR *p* ≤ 0.05) in multivariable models adjusting for age, sex, total caloric intake, current smoking, physical activity index, lipid lowering medication, anti-hypertensive medication, and body mass index. CE, cholesterol ester; FDR, false discovery rate; LPC, lysophosphatidylcholine; LPE, lysophosphatidylethanolamine; PC, phosphatidylcholine; SM, sphingomyelin; TAG, triacylglycerol.](nutrients-12-01476-g004){#nutrients-12-01476-f004}
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###### 

Sample characteristics at examination five of the Framingham Offspring Study.^1^

                                                    Men             Women
  ------------------------------------------------- --------------- ---------------
  Age, yr                                           55.7 ± 9.9      54.5 ± 9.6
  Current smoker, n (%)                             190 (18%)       210 (18%)
  Physical activity score                           36.0 ± 7.4      33.4 ± 4.7
  BMI, kg/m^2^                                      28.2 ± 4.1      26.7 ± 5.4
  Lipid-lowering medications, n (%)                 101 (10)        67 (6)
  Anti-hypertensive medication, n (%)               238 (23)        195 (17)
  Energy intake, kcal/day                           1992 ± 642      1742 ± 566
  AHEI (0--110)                                     48.0 ± 9.6      51.7 ± 9.7
  DASH (0--40)                                      23.0 ± 4.9      25.3 ± 4.7
  MDS (0--25)                                       12.3 ± 4.3      12.0 ± 4.4
  Food Group Intake                                                 
   Vegetables, svg/d                                2.0 ± 1.3       2.4 ± 1.7
   Fruits, svg/d                                    1.2 ± 1.0       1.4 ± 1.2
   Low-fat dairy, svg/d                             0.8 ± 0.9       0.9 ± 1.0
   Nuts, svg/wk                                     0.4 ± 0.6       0.2 ± 0.4
   Legumes, svg/wk                                  0.3 ± 0.3       0.3 ± 0.3
   Whole grains, svg/wk                             1.2 ± 1.2       1.2 ± 1.2
   Red/processed meat, svg/wk                       0.9 ± 0.7       0.6 ± 0.5
   Fish, svg/wk                                     0.3 ± 0.3       0.3 ± 0.3
   Sugar-sweetened beverage & fruit juice, svg/wk   1.4 ± 1.2       1.1 ± 1.2
   Sugar-sweetened beverage, svg/wk                 0.5 ± 0.8       0.3 ± 0.6
   Fruit juice, svg/wk                              0.9 ± 0.9       0.8 ± 0.9
   Alcohol, gm/day                                  15.4 ± 20.0     6.7 ± 11.2
   MUFA:SFA                                         1.1 ± 0.2       1.1 ± 0.2
   MUFA, %kcal                                      11.3 ± 2.7      10.9 ± 2.6
   SFA, % kcal                                      10.5 ± 3.0      10.3 ± 2.8
   PUFA, % kcal                                     5.7 ± 1.7       6.0 ± 1.7
   Trans fat, % kcal                                1.6 ± 0.8       1.4 ± 0.7
   Omega-3 fatty acids, mg/day                      257.8 ± 235.5   253.2 ± 217.8

^1^ Values presented as mean and standard deviation or proportion and frequency. Abbreviations: AHEI, Alternative Healthy Eating Index; BMI: body mass index; DASH, Dietary Approaches to Stop Hypertension; MDS, Mediterranean Diet-style Score; MUFA, Monounsaturated fatty acid; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids.

nutrients-12-01476-t002_Table 2

###### 

Top significant associations of dietary patterns with plasma protein concentrations ^1^.

  Name                                                                                    Type/Class                Diet ^2^          AHEI        DASH    MDS                             
  --------------------------------------------------------------------------------------- ------------------------- ----------------- ----------- ------- ----------- ------- ----------- -------
  Carbonic anhydrase 6                                                                    Enzyme                    DASH              0.095       0.023   0.108 \*    0.023   0.085       0.025
  Carnosine dipeptidase 1 (CNDP1)                                                         Peptidase                 AHEI, DASH        0.135 \*    0.024   0.105 \*    0.025   0.085       0.026
  Contactin 4                                                                             Enzyme                    DASH              0.051       0.024   0.112 \*    0.024   0.075       0.025
  Epidermal growth factor receptor (ERBB1)                                                Kinase                    AHEI, MDS, DASH   0.133 \*    0.022   0.127 \*    0.023   0.111 \*    0.024
  Fibroblast growth factor receptor 1 (bFGF-R)                                            Kinase                    AHEI,DASH         0.092 \*    0.023   0.107 \*    0.023   0.076       0.024
  Galectin 3                                                                              Other                     AHEI              0.101 \*    0.023   0.073       0.024   0.076       0.025
  Glypican 3                                                                              Other                     DASH              0.057       0.024   0.109 \*    0.024   0.070       0.025
  Hemojuvelin BMP co-receptor (RGM-C)                                                     Other                     DASH              0.090       0.024   0.105 \*    0.025   0.088       0.026
  Heterogeneous nuclear ribonucleoprotein A/B (hnRNP A/B)                                 Enzyme                    DASH              −0.054      0.023   −0.099 \*   0.024   −0.042      0.025
  Kynureninase (KYNU)                                                                     Enzyme                    AHEI, MDS, DASH   −0.127 \*   0.024   −0.153 \*   0.024   −0.112 \*   0.026
  Leucine rich repeats and immunoglobulin like domains 3 (LRIG3)                          Other                     AHEI              0.114 \*    0.024   0.087       0.025   0.069       0.026
  Macrophage migration inhibitory factor (MIF)                                                                      MDS, DASH         −0.098      0.024   −0.119 \*   0.024   −0.106 \*   0.026
  Matrix metallopeptidase 2 (MMP-2)                                                       Peptidase                 DASH              0.076       0.024   0.117 \*    0.024   0.074       0.025
  MET proto-oncogene, receptor tyrosine kinase (MET)                                      Kinase                    AHEI              0.102 \*    0.023   0.096       0.024   0.050       0.025
  Notch 1                                                                                 Transcription regulator   AHEI, DASH        0.098 \*    0.023   0.113 \*    0.023   0.069       0.024
  Peroxiredoxin 1                                                                         Enzyme                    DASH              −0.068      0.024   −0.113 \*   0.025   −0.077      0.026
  Plasminogen activator, tissue type (tPA)                                                Peptidase                 DASH              −0.048      0.022   −0.101 \*   0.022   −0.068      0.023
  Serpin family C member 1 (Antithrombin III)                                             Enzyme                    AHEI              0.093 \*    0.021   0.063       0.022   0.053       0.023
  Stanniocalcin 1                                                                         Kinase                    AHEI, MDS, DASH   −0.108 \*   0.024   −0.103 \*   0.024   −0.111 \*   0.025
  Thrombospondin 2 (TSP2)                                                                 Other                     AHEI              −0.112 \*   0.024   −0.087      0.025   −0.077      0.026
  Transferrin                                                                             Transporter               AHEI              0.127 \*    0.022   0.083       0.023   0.068       0.024
  WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 (WFKN2)   Other                     AHEI, DASH        0.095 \*    0.023   0.097 \*    0.023   0.099       0.024
  Prostatic binding protein                                                                                         DASH              −0.046      0.024   −0.101 \*   0.024   −0.042      0.026

^1^ Multivariable regression models with proteins as the dependent variable and dietary pattern scores as the independent variable (separate model for each dietary pattern and protein). Models are adjusted for age, sex, total caloric intake, current smoking, physical activity index, lipid lowering medication, anti-hypertensive medication, and body mass index. \* Statistically significant following Bonferroni adjustment (0.05/1373 proteins). ^2^ Diets with a statistically significant association. ^3^ β estimates represent the change in protein concentration per standardized unit increase in the respective dietary pattern indices. Abbreviations: AHEI, Alternative Healthy Eating Index; DASH, Dietary Approaches to Stop Hypertension; MDS, Mediterranean Diet-style Score.
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###### 

Top significant associations of dietary patterns with plasma metabolite concentrations ^1.^

  Name                                   Type\\Class                         Diet ^2^          AHEI                DASH                MDS         
  -------------------------------------- ----------------------------------- ----------------- ----------- ------- ----------- ------- ----------- -------
  Aconitate                              Aliphatic acyclic compound          AHEI, DASH        −0.025 \*   0.006   −0.025 \*   0.006   −0.019      0.007
  Cholesterol ester (C22:6)              Lipid                               AHEI, MDS         0.059 \*    0.015   0.048       0.016   0.080 \*    0.017
  Cis/trans-hydroxyproline               L-alpha-amino acid                  MDS, DASH         −0.033      0.012   −0.070 \*   0.012   −0.054 \*   0.013
  Cotinine                                                                   MDS, DASH         −2.094      0.723   −3.075 \*   0.734   −3.097 \*   0.772
  Hippurate                              Aromatic homomonocyclic compounds   AHEI, MDS, DASH   0.364 \*    0.079   0.430 \*    0.080   0.354 \*    0.085
  Isocitrate                             Aliphatic acyclic compounds         AHEI, MDS, DASH   −0.041 \*   0.008   −0.049 \*   0.008   −0.041 \*   0.008
  Lysophosphatidylcholine (C20:5)        Lipid                               AHEI, DASH        0.079 \*    0.016   0.069 \*    0.017   0.062       0.018
  Lysophosphatidylcholine (C22:6)        Lipid                               AHEI, MDS, DASH   0.073 \*    0.010   0.052 \*    0.011   0.077 \*    0.011
  Lysophosphatidylethanolamine (C20:4)   Lipid                               MDS               −0.022      0.009   −0.028      0.009   −0.045 \*   0.010
  Ornithine                              L-alpha-amino acid                  DASH              −0.028      0.011   −0.057 \*   0.011   −0.039      0.012
  Oxalate                                Aliphatic acyclic compounds         MDS, DASH         0.064       0.018   0.107 \*    0.018   0.086 \*    0.019
  Pantothenate                           Water-soluble vitamins              DASH              0.049       0.022   0.126 \*    0.022   0.083       0.023
  Phosphatidylcholine (C38:6)            Lipid                               AHEI, MDS, DASH   0.039 \*    0.005   0.035 \*    0.005   0.046 \*    0.005
  Phosphatidylcholine (40:6)             Lipid                               AHEI, MDS, DASH   0.041 \*    0.006   0.038 \*    0.006   0.054 \*    0.006
  Serine                                 Amino acid                          DASH              −0.006      0.007   −0.030 \*   0.007   −0.018      0.008
  Sphingomyelin (C14:0)                  Lipid                               MDS               −0.012      0.006   −0.001      0.007   −0.043 \*   0.007
  Sphingomyelin (C18:0)                  Lipid                               AHEI, MDS, DASH   −0.026 \*   0.006   −0.028 \*   0.006   −0.032 \*   0.006
  Sphingomyelin (C18:1)                  Lipid                               AHEI, MDS, DASH   −0.044 \*   0.007   −0.044 \*   0.007   −0.036 \*   0.007
  Thiamine                               Water-soluble vitamins              DASH              0.067       0.037   0.150 \*    0.037   0.101       0.039
  Triacylglycerol (C54:7)                Lipid                               MDS               0.036       0.012   0.037       0.012   0.050 \*    0.013
  Triacylglycerol (C56:7)                Lipid                               AHEI, MDS, DASH   0.037 \*    0.007   0.031 \*    0.007   0.041 \*    0.008
  Triacylglycerol (C56:8)                Lipid                               AHEI, MDS, DASH   0.043 \*    0.009   0.040 \*    0.009   0.054 \*    0.009
  Triacylglycerol (C58:10)               Lipid                               AHEI, MDS, DASH   0.045 \*    0.010   0.038 \*    0.010   0.048 \*    0.011
  Triacylglycerol (C58:8)                Lipid                               AHEI, MDS, DASH   0.042 \*    0.008   0.037 \*    0.008   0.047 \*    0.008
  Triacylglycerol (C58:9)                Lipid                               AHEI, MDS, DASH   0.050 \*    0.009   0.045 \*    0.009   0.057 \*    0.009
  Uridine                                Ribonucleosides                     AHEI, DASH        0.028 \*    0.005   0.034 \*    0.005   0.019       0.005

^1^ Multivariable regression models with each metabolite as the dependent variable and dietary pattern scores as the independent variable (separate model for each dietary pattern and protein). Models are adjusted for age, sex, total caloric intake, current smoking, physical activity index, lipid lowering medication, anti-hypertensive medication, and body mass index. \* Statistically significant following Bonferroni adjustment (0.05/216 metabolites). ^2^ Diets with a statistically significant association. ^3^ β estimates represent the change in metabolite concentration per standardized unit increase in the respective dietary pattern indices Abbreviations: AHEI, Alternative Healthy Eating Index; DASH, Dietary Approaches to Stop Hypertension; MDS, Mediterranean Diet-style Score.
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###### 

Pathway over representation analysis of protein markers associated with dietary pattern ^1.^

             Pathway                                  Enrichment Ratio   *P*-Value ^2^   FDR Q-Value ^3^   Matched Molecules
  ---------- ---------------------------------------- ------------------ --------------- ----------------- -----------------------------------------------------------------
  hsa04610   Complement and coagulation cascades      12.51              3.1 × 10^8^     1.0 × 10^5^       PLAT, SERPINC1, C3, SERPINE1, SERPINA5, CFH, C1S, C3AR1, CPB2
  hsa05150   Staphylococcus aureus infection          9.81               1.4 × 10^4^     1.7 × 10^2^       C3, CFH, C1S, SELP
  hsa01522   Endocrine resistance                     6.72               2.5 × 10^4^     1.7 × 10^2^       EGFR, MMP2, BCL2, NOTCH1, MED1, JAG1
  hsa04066   HIF-1 signaling pathway                  6.59               2.8 × 10^4^     1.7 × 10^2^       EGFR, GAPDH, SERPINE1, TEK, TF, BCL2
  hsa05230   Central carbon metabolism in cancer      8.45               2.9 × 10^4^     1.7 × 10^2^       EGFR, FGFR1, KIT, MET, NTRK3
  hsa04151   PI3K-Akt signaling pathway               3.41               3.1 × 10^4^     1.7 × 10^2^       CDC37, EGFR, FGFR1, HSP90AB1, MET, TEK, THBS2, BCL2, KIT, YWHAB
  hsa05144   Malaria                                  8.97               9.8 × 10^4^     4.6 × 10^2^       MET, SELE, SELP, THBS2
  hsa05418   Fluid shear stress and atherosclerosis   4.74               1.6 × 10^3^     6.2 × 10^2^       HSP90AB1, MMP2, PLAT, BCL2, SELE, BMPR1A
  hsa05215   Prostate cancer                          5.66               1.8 × 10^3^     6.2 × 10^2^       EGFR, PLAT, HSP90AB1, FGFR1, BCL2
  hsa04514   Cell adhesion molecules (CAMs)           4.58               1.9 × 10^3^     6.2 × 10^2^       SELP, SELE, CNTN1, NEGR1, PDCD1LG2, NRXN3

^1^ All proteins analyzed were significantly (FDR q ≤ 0.05) related to the respective dietary pattern scores in multivariable models adjusting for age, sex, total caloric intake, current smoking, physical activity index, lipid lowering medication, anti-hypertensive medication, and body mass index. Analyzed proteins were annotated to KEGG pathways with \>5 and \<2000 proteins. ^2^ Unadjusted p value. ^3^ False discovery rate p value. Abbreviations: AHEI, Alternative Healthy Eating Index; DASH, Dietary Approaches to Stop Hypertension; KEGG, Kyoto Encyclopedia of Genes and Genomes; MDS, Mediterranean-style Diet Score.
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###### 

Overlap among dietary protein quantitative trait loci and prior genome-wide association study risk loci.^1.^

  Protein ^1^            Variant ^2^         Nearest Gene   GWAS Associated Traits ^3^                                                                                                                      GWAS Study Accession ^4^
  ---------------------- ------------------- -------------- ----------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------
  AK1A1                  rs72688441          NASP           Blood protein concentrations                                                                                                                    GCST006585, GCST005806
  AK1A1                  1:46767127:TCTC\_   LRRC41                                                                                                                                                         
  AK1A1                  rs72684498          ZSWIM5                                                                                                                                                         
  AK1A1                  rs72676591          EIF2B3                                                                                                                                                         
  Antithrombin III       rs334516            TNS3                                                                                                                                                           
  bFGF-R                 8:38324424:ACC_A    FGFR1                                                                                                                                                          
  C1s                    rs6695321           CFH            Blood protein concentrations                                                                                                                    GCST004365, GCST005806
  C1s                    rs150845796         CFHR2                                                                                                                                                          
  C3a                    rs11583804          ACTRT2                                                                                                                                                         
  Cadherin-5             rs8176672           ABO            Blood protein concentrations, optic cup area                                                                                                    GCST005806, GCST004137
  Cadherin-5             rs11534419          TMEM8C                                                                                                                                                         
  Carbonic anhydrase 6   rs11576766          CA6                                                                                                                                                            
  Cathepsin D            rs1558500                                                                                                                                                                          
  Cathepsin S            rs72702561          HORMAD1        Blood protein concentrations                                                                                                                    GCST006585
  Cathepsin S            rs9661107           PRUNE1                                                                                                                                                         
  Cathepsin S            rs141935877         TARS2                                                                                                                                                          
  Contactin-1            rs11640313          MRPL28                                                                                                                                                         
  ERBB1                  rs12112554                                                                                                                                                                         
  Factor H               rs10737680          CFH            Macular degeneration, lung function, blood protein concentrations                                                                               GCST004737, GCST003265, GCST004365
  Factor H               rs12134610          KCNT2                                                                                                                                                          
  Factor H               rs150845796         CFHR2                                                                                                                                                          
  Factor H               rs1329428                          Macular degeneration, central serous retinopathy, lung function                                                                                 GCST000806, GCST006416, GCST003265
  Gal 3                  rs11733361          SLC25A31                                                                                                                                                       
  iC3b                   rs11583804          ACTRT2                                                                                                                                                         
  IGFBP-1                rs139504202                                                                                                                                                                        
  KYNU                   rs35647509          KYNU                                                                                                                                                           
  KYNU                   rs4733300           NRG1                                                                                                                                                           
  LSAMP                  rs117955663         OR56B2P                                                                                                                                                        
  MET                    rs635634            ABO            Blood protein concentrations, LDL-C concentrations, TC concentrations, ischemic stroke, immune cell count, T2D                                  GCST000759, GCST000760, GCST006910, GCST004613, GCST004773, GCST005806
  Notch 1                rs138015312         UGT2B15                                                                                                                                                        
  PARC                   rs1102934           CCL18          Blood protein concentrations                                                                                                                    GCST006585
  RGM-C                  rs2381409           FAM221B                                                                                                                                                        
  RGM-C                  7:57407593:TTCC\_                                                                                                                                                                  
  sE-Selectin            rs2519093           ABO            Blood protein concentrations, LDL-C concentrations, venous thromboembolism, TC concentrations, hematocrit, hemoglobin, immune cell count, CAD   GCST005806, GCST006612, GCST004256, GCST007143, GCST005994, GCST005995, GCST007070, GCST005195
  sE-Selectin            rs9722289           TMEM8C                                                                                                                                                         
  TIG2                   rs10282458          LOC107986858                                                                                                                                                   
  Transferrin            rs71544591          PTPRN2                                                                                                                                                         
  TSP2                   rs73043837          THBS2                                                                                                                                                          
  WFKN2                  rs7207028           WFIKKN2                                                                                                                                                        

^1^ Proteins whose concentrations were significantly associated (FDR q ≤ 0.05) with at least one dietary pattern index and had a pQTL previously identified in the Framingham Offspring Study \[[@B26-nutrients-12-01476]\]. ^2^ Previously identified pQTL. ^3^ Top traits associated with corresponding GWAS risk loci. A complete list of traits can be found in the NHGRI-EBI Catalogue of Published GWAS. ^4^ GWAS Study accession number of studies linking GWAS risk loci and traits. A complete list of GWAS Study accession number can be found in the NHGRI-EBI Catalogue of Published GWAS. CAD, coronary artery disease; GWAS, genome-wide association study; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; T2D; diabetes mellitus; QTL, quantitative trait loci.
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###### 

Overlap among dietary metabolite quantitative trait loci and prior genome-wide association study risk loci.^1^

  Metabolite ^1^                         Variant ^2^   Nearest Gene     GWAS Associated Traits ^3^                                                                                                                                                                GWAS Study Accession^4^
  -------------------------------------- ------------- ---------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------
  Cholesterol ester (C20:5)              rs174548      FADS1-2          Blood metabolite concentrations, metabolite ratios in CKD, TG concentrations, HDL-C concentrations, plasma N6 concentrations, metabolite ratios                                           GCST000274, GCST005650, GCST000809, GCST000805, GCST003237, GCST002442
  Indoxylsulfate                         rs875480      CSNK1G3                                                                                                                                                                                                    
  Lysophosphatidylcholine (C20:5)        rs174548      FADS1-2          Blood metabolite concentrations, metabolite ratios in CKD, TG concentrations, HDL-C concentrations, plasma N6 concentrations, metabolite ratios                                           GCST000274, GCST005650, GCST000809, GCST000805, GCST003237, GCST002442
  Lysophosphatidylcholine (C22:6)        rs174550      FADS1-2          Blood metabolite concentrations, TG concentrations, FBG, HDL-C concentrations, LDL-C concentrations, plasma N6 concentrations, plasma N3 concentrations, HOMA-B                           GCST002443, GCST004237. GCST005186, GCST004232, GCST007141, GCST002446, GCST001178, GCST005180,
  Lysophosphatidylethanolamine (C18:2)   rs4246215     FADS2            Plasma N3 concentrations, platelet count, IBD, RBC fatty acid concentrations, Crohn's disease, CRC                                                                                        GCST001180, GCST001337, GCST001725, GCST002712, GCST004132, GCST007992
  Lysophosphatidylethanolamine (C20:4)   rs174548      FADS1-2          Blood metabolite concentrations, metabolite ratios in CKD, TG concentrations, HDL-C concentrations, plasma N6 concentrations, metabolite ratios                                           GCST000274, GCST005650, GCST000809, GCST000805, GCST003237, GCST002442
  Lysophosphatidylethanolamine (C20:4)   rs4149056     SLCO1B1          Blood metabolite concentrations, TG concentrations, bilirubin, response to statin, ER+ breast cancer, thyroxine concentrations, hemoglobin, metabolite ratios                             GCST002442, GCST007133, GCST000386, GCST000213, GCST004359, GCST006896, GCST007068, GCST002442
  Phosphatidylcholine (C36:2)            rs174541      FADS2            Blood metabolite concentrations, metabolite ratios in CKD, *trans* fatty acid concentrations, RBC fatty acids,                                                                            GCST001852, GCST005650, GCST002721, GCST002712
  Phosphatidylcholine (C40:6)            rs174535      FADS1-2          Blood metabolite concentrations, plasma N3 concentrations, RBC fatty acids, *trans* fatty acid concentrations, inflammatory disease, asthma, glycemic traits, respiratory disease         GCST002443, GCST001178, GCST002712, GCST002721, GCST005537, GCST007799, GCST008674, GCST007076
  Proline                                rs2078743     PRODH                                                                                                                                                                                                      
  Serine                                 rs477992      PHGDH            Blood metabolite/amino acid concentrations, TC concentrations                                                                                                                             GCST002966, GCST006614
  Sphingomyelin (C14:0)                  rs11158519    SYNE2            Sphingomyelin concentrations                                                                                                                                                              GCST008933
  Triacylglycerol (C54:2)                rs964184      APOA1/C3/A4/A5   Blood metabolite concentrations, TG concentrations, lipoprotein concentrations, CHD, stroke, MetS, phospholipid fatty acids, fat soluble vitamin concentrations, CAD, age related CVDs    GCST001639, GCST004550, GCST004759, GCST000998, GCST002290, GCST001436, GCST001414, GCST001142, GCST004787, GCST004045,
  Triacylglycerol (C54:4)                rs174550      FADS1-2          TG concentrations, FBG, HDL-C concentrations, LDL-C concentrations, plasma N6 concentrations, HOMA-B, plasma N3 concentrations, RBC fatty acids, *trans* fatty acid concentrations        GCST004237, GCST008032, GCST004232, GCST007141, GCST002448, GCST005180, GCST001178, GCST002712, GCST002721
  Triacylglycerol (C54:5)                rs964184      APOA1/C3/A4/A5   Blood metabolite concentrations, TG concentrations, lipoprotein concentrations, CHD, stroke,, MetS, phospholipid fatty acids, fat soluble vitamin concentrations, CAD, age related CVDs   GCST001639, GCST004550, GCST004759, GCST000998, GCST002290, GCST001436, GCST001414, GCST001142, GCST004787, GCST004045,
  Triacylglycerol (C56:7)                rs6593086                                                                                                                                                                                                                
  Triacylglycerol (C58:10)               rs174548      FADS1-2          Blood metabolite concentrations, metabolite ratios in CKD, TG concentrations, HDL-C concentrations, plasma N6 concentrations, metabolite ratios                                           GCST000274, GCST005650, GCST000809, GCST000805, GCST003237, GCST002442
  Triacylglycerol (C58:8)                rs6593086                                                                                                                                                                                                                
  Triacylglycerol (C58:9)                rs6593086                                                                                                                                                                                                                

^1^ Metabolites whose concentrations were significantly associated (FDR q ≤ 0.05) with at least one dietary pattern index and had a mQTL previously identified in the Framingham Offspring Study (26). ^2^ Previously identified mQTL. ^3^ Top traits associated with corresponding GWAS risk loci. A complete list of traits can be found in the NHGRI-EBI Catalogue of Published GWAS. ^4^ GWAS Study accession number of studies linking GWAS risk loci and traits. A complete list of GWAS Study accession number can be found in the NHGRI-EBI Catalogue of Published GWAS.
